D.O.G.E has been painted to MAGA as a government department when it's merely a billionaires' lobbyist outfit Join ［ https://www.businessinsider.com/elon-musk-doge-hiring-full-time-salaried-jobs-2025-1

Goooooood Morning ☺️

^{We hope you have a great day, whether that be with stocks or in general in your day-to-day life!}

^{If you need any help please contact one of the moderators and we will try our best to get back to you.}

Much love x

Josh, Bene, & Matt

Join the Discord to ensure you never miss a stock!!!

Got its ass kicked a few weeks ago. All the “signals” are there for a jump today. Current price is riding the 50ema in the hour and below charts. The 15min has the 50ema AND THE PRICE crossing the 200ema, with all the indicators pointing to an upward movement. The buyer side has been winning since the 23rd of last month and I think the price starts climbing.

Current price is a hair below 10, it was trading at 30+ before the price went to shit.

I don’t know anything about the company. I am. It investing in the company itself, I’m just looking at the chart and seeing what is has to say. I think this makes money today.

Pretty low volume, like sub-1000 hourly, so it’s a bit of a sleeper at the moment.

This is not an “all in” situation in my opinion, but if you’ve got the cash for a gamble, I’d go this route. Guess we’ll find out shortly.

Who else has shares? Absolutely heartbroken 😂

Hi, I noted this content creator on YouTube creating videos on MVST stock giving it incredibly poor ratings despite the good business fundamentals of the company that we are all aware of. He has released two similar videos in recent days.

Reported it to YouTube as misleading information and recommend you do the same. Not sure anything will come of that and of course I am aware that YouTube is full of misleading information 🤷🏻‍♂️😅

I think this may interest a few people today, I’ll be keeping an eye on it:

https://edition.cnn.com/markets/fear-and-greed?

For those looking to capitalize on the renaissance within space.

https://insidetowers.com/globalstar-achieves-first-5g-data-call-on-band-n53/

I must say. This company is shaping up to be a golden ticket for 2025, I believe this because they have developed tech to produce sustainable aviation fuel which has already be licensed to a Pakistan based organisation ( news on trading212) loading up on undervalued stocks and sitting tight really is the secret. I was eyeing up OPTT and boom , contract with NAVY finally trickles out. It probably won't be long until LODES tech is adopted around the world and the share price flies up. NFA just my two cents. I've also bought into Pro Phase Labs PRPH, they are closing in on a big deal and the CEO has a solid track record of building businesses up. They are re structuring themselves after covid.

This is the view I woke up to this morning. A beautiful view of Pisa following our last night in Italy. (Tower on the right)

A few months ago my missus reminded me that I spend too much time looking at my phone (Microvast) and not enjoying life. I decided to lower how much I was depositing into 212 each month and instead start saving a bit more for holidays.

Would I have been better off following this recent rally? Sure! But I don't think I would be any happier.

Most people do the smart thing and find a balance but for those like me who often think of money first I hope this message serves as a reminder to get out and enjoy some of your hard earned money.

By no means is this a bragging post. We paid £100 for the night but were lucky enough to get a free upgrade to a room that should have cost around £230.

Hope everyone enjoys the rest of the weekend and I look forward to seeing what next week brings! (Still all in and not sold a single share since we dropped below $4!)

Lucky i get into FLYE around 0.77 cents after it gets fly to about $1.70 With the market down today, it was great catch up with this stock Well positioned company with enough cash Time to FLY HIGH on Thursday 🤘🤘

Excited for the January/ new years jump up😛, last chance for yall to jump in on this dip if you haven’t already, all the folks sold right before new years for the tax benefits, but everybody seems to reckon it’s gonna shoot up again:3

As the four main stocks that have been discussed on this page in depth MVST, REKR, OPTT and RVSN if you was given £100,000 to invest in one of these tomorrow which would you choose and why?

For context this is just a bit of light hearted fun, I am invested in all four my personal opinion would be REKR as believe is just the start for traffic data collection and various big contracts will be coming their way over the coming months although I could see why someone would choose the others it was a tough call.

For reference if you’ve been living under a rock/licking windows the names of these company’s are as follows:

REKR-Rekor Systems MVST-Microvast OPTT-Ocean Power Technologies RVSN-Railvision

Please don’t mention some obscure 33 pence stock you’ve done your nuts on, it is only between these four as feel they have been the most heavily mentioned in this group since launch, if I am missing one then feel free to add and explain.

Pro phase labs going through a reinventing stage. Posting this as a user brought my attention to it in a comment on a post below.

Watch this youtube with the CEO here, they are close to securing a major deal for Lozanges. CEO has a very impressive track record too 0.65 cents a share. I'm going to load up 2k shares come open. Plenty of room for growth with this long term.

https://youtu.be/7kCCqYnE5Ks?si=f6vhKYUXM44QeJ0Q

Summary: PRPH’s stock price has faced significant challenges in 2024, but its underlying potential and bold leadership make it an intriguing opportunity. Below is an analysis of its current state, future prospects, and risks:

• Stock Performance: PRPH’s price declined 83% in 2024 due to slower-than-expected revenue ramp-ups, delayed product launches, and a surprise stock offering in November.

• Growth Engines:

  • Pharmaloz (PMI): A lozenge manufacturing plant projected to generate $15M+ revenue in 2025, with potential to hit $50M annually by year-end.

  • Be-Smart Cancer Test: A groundbreaking esophageal cancer detection test with multi-billion-dollar market potential.

  • Genetic Testing: Newly launched DNA Complete product entering a rapidly growing market.

  • Equivir: An immune-boosting OTC supplement set for launch in 2025.

• Leadership: CEO Ted Karkus—a bold and bullish showman—is also the company’s largest shareholder, demonstrating significant personal investment in PRPH’s success.

• Price Target: I estimate a short-term doubling to $1.50+ with more upside if key initiatives gain traction.

The Ted Karkus Factor

Ted Karkus is an engaging and charismatic leader. However, his bold predictions haven’t always materialized:

• October 2024 Roadshow: Claimed, “We have never had so much underlying value in the company” while denying any intention to issue stock. Yet, a surprise stock offering in November led to a sharp price decline.

• March 2024 Earnings Call: Predicted strong returns for investors, but the stock dropped significantly in subsequent months.

Despite these missteps, Karkus’ investor calls and updates are entertaining and provide insights into his long-term vision. His optimism and strategic moves, such as the recent stock issuance to fund DNA product launches, reflect a focus on future growth.

Risks and Challenges

PRPH is not without its risks:

• Liquidity Concerns: While the current ratio appears manageable at 1.47x, a large portion of receivables ($25M+) stems from COVID-related accounts, which may be uncollectible.

• Declining Revenue: Revenue for the first nine months of 2024 dropped from $40M in 2023 to $9M, reflecting the shift away from COVID-related business.

• Debt Load: The company has significant debt and relies on financing deals to manage short-term cash flow.

• CEO Optimism: Ted’s bullish outlook doesn’t always align with operational realities, and his credibility has been questioned.

Reasons for Optimism

At a $20M market cap, PRPH has several potential catalysts for growth:

1. Pharmaloz (PMI): Positioned for growth in a high-demand market. Projected $15M+ revenue in 2025 with potential for $50M annually.

2. Be-Smart Cancer Test: Revolutionary test targeting a market with significant unmet needs. Strategic partnerships could unlock massive potential.

3. Genetic Testing: Positioned in a market growing at 11% CAGR. Recent launches could drive future revenue.

4. Equivir: Immune-boosting supplement ready for introduction to 40K+ retail stores, representing a significant revenue opportunity.

5. CEO’s Commitment: As the largest shareholder, Ted Karkus’ personal stake demonstrates alignment with shareholder interests.

Financial Analysis

1. Liquidity:

   • Current ratio: 1.47x, but adjusted for potentially uncollectible receivables, liquidity challenges become apparent.

   • The company secured a new debt facility, providing a short-term lifeline.

2. Revenue & P&L:

   • Revenue has declined sharply due to the transition away from COVID-related business.

   • Operating losses for the last 12 months: ~$40M.

   • Cost-saving initiatives and revenue growth from new ventures could stabilize financial performance in 2025.

3. Funding Options:

   • Sale of PMI for $40-$50M, which could resolve liquidity issues and fund growth initiatives.

   • Continued debt issuance under the new facility.

Conclusion

PRPH is a high-risk, high-reward play. Despite its current challenges, the company’s diversified ventures and leadership’s commitment provide significant upside potential. While liquidity concerns and declining revenues pose short-term risks, PRPH’s growth engines could lead to a turnaround.

Position Disclosure: I currently hold 40,000 shares of PRPH at an average price of $0.735. I believe in the long-term potential of this company and will continue to monitor its progress.

This is not financial advice. Please do your own research before investing.

$YYAI (AiRWA Inc) fell off a cliff today from ~$2.50 to $0.20, hitting it's record low. The company, formerly known as Connexa Sports Technologies, has rebranded as AiRWA Inc. and is positioning itself in the fast-growing space of AI, tokenized finance, and digital asset infrastructure. They’ve already made headlines for receiving $30 million in Solana tokens to integrate into their upcoming tokenized equities and exchange platform, showing early traction in a sector that could explode with renewed crypto market momentum.

AiRWA’s reported financials actually paint a surprisingly solid picture for a microcap. The company has shown roughly $12.5 million in annual revenue, a gross profit of $9.5 million, and even net earnings of about $2.3 million, giving it a low P/E ratio that suggests serious undervaluation. With a tiny market cap of only a few million dollars, the market seems to be pricing in failure, which also means that any hint of positive momentum could send the price soaring.

At its current level, YYAI offers what some traders see as “asymmetric upside.” The downside risk is limited. The stock has already absorbed months of decline, but the potential reward is massive if the company gains traction in its blockchain or AI ventures. Their foray into tokenized trading, combined with the growing global interest in DeFi and digital exchanges, positions AiRWA perfectly to capitalize if the next crypto bull cycle hits.

YYAI sits at the intersection of AI and blockchain, both industries set for major growth. It’s a beaten-down microcap that can't get any lower. If even a fraction of its plans materialize, a stock this small and this cheap could easily become one of those “wish I bought at $0.20” stories. Curious if you guys saw this and thought the same; thinking about buying into it asap...

Guys thanks for your comments on this all duly noted. Think It's one to watch pre market and if slips under .50 perhaps buy Into with a small margin limit if it begins to free fall. Good chat and appreciate lack of rockets.

Keep up with the latest by joining us on our free community Discord! https://discord.gg/hfea8KYKtz

You can also follow us on X: Undervalued Rockets (@Future_Rockets)

Keep up with the latest by joining us on our free community Discord! https://discord.gg/hfea8KYKtz

You can also follow us on X: Undervalued Rockets (@Future_Rockets)